State Of New Jersey Common Pension Fund D Adaptive Biotechnologies Corp Transaction History

State Of New Jersey Common Pension Fund D

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 28, 2022	SELL	$6.5 - $12.67 $495,989 - $966,797	-76,306 Reduced 25.9%	218,339 $1.56 Million
Q2 2022 Aug 04, 2022	BUY	$6.4 - $14.73 $695,590 - $1.6 Million	108,686 Added 58.45%	294,645 $2.38 Million
Q1 2022 May 03, 2022	BUY	$10.12 - $28.9 $842,662 - $2.41 Million	83,267 Added 81.08%	185,959 $2.58 Million
Q4 2021 Jan 31, 2022	BUY	$25.17 - $36.85 $377,273 - $552,344	14,989 Added 17.09%	102,692 $2.88 Million
Q3 2021 Oct 27, 2021	BUY	$30.02 - $39.87 $514,812 - $683,730	17,149 Added 24.31%	87,703 $2.98 Million
Q2 2021 Jul 23, 2021	BUY	$32.22 - $44.59 $455,204 - $629,967	14,128 Added 25.04%	70,554 $2.88 Million
Q1 2021 Apr 27, 2021	BUY	$37.26 - $67.74 $165,620 - $301,104	4,445 Added 8.55%	56,426 $2.27 Million
Q4 2020 Feb 03, 2021	SELL	$45.01 - $65.47 $165,591 - $240,864	-3,679 Reduced 6.61%	51,981 $3.07 Million
Q3 2020 Oct 27, 2020	SELL	$35.79 - $48.81 $84,714 - $115,533	-2,367 Reduced 4.08%	55,660 $2.71 Million
Q2 2020 Aug 04, 2020	BUY	$24.95 - $48.38 $1.45 Million - $2.81 Million	58,027 New	58,027 $2.81 Million

202

146M

68.8K

42.5K

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $849M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

Get notified when there are updates to the investment portfolio of State Of New Jersey Common Pension Fund D, based on Form 13F filings with the SEC.

Stay updated on State Of New Jersey Common Pension Fund D with notifications on news.